当前位置: X-MOL 学术JAMA › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Effect of Remote Ischemic Conditioning vs Usual Care on Neurologic Function in Patients With Acute Moderate Ischemic Stroke: The RICAMIS Randomized Clinical Trial.
JAMA ( IF 63.1 ) Pub Date : 2022-08-16 , DOI: 10.1001/jama.2022.13123
Hui-Sheng Chen 1 , Yu Cui 1 , Xiao-Qiu Li 1 , Xin-Hong Wang 1 , Yu-Tong Ma 2 , Yong Zhao 3 , Jing Han 4 , Chang-Qing Deng 5 , Mei Hong 6 , Ying Bao 7 , Li-Hong Zhao 8 , Ting-Guang Yan 9 , Ren-Lin Zou 10 , Hui Wang 11 , Zhuo Li 4 , Li-Shu Wan 12 , Li Zhang 13 , Lian-Qiang Wang 14 , Li-Yan Guo 15 , Ming-Nan Li 16 , Dong-Qing Wang 17 , Qiang Zhang 18 , Da-Wei Chang 19 , Hong-Li Zhang 20 , Jing Sun 21 , Chong Meng 22 , Zai-Hui Zhang 23 , Li-Ying Shen 24 , Li Ma 25 , Gui-Chun Wang 26 , Run-Hui Li 25 , Ling Zhang 27 , Cheng Bi 5 , Li-Yun Wang 28 , Duo-Lao Wang 29 ,
Affiliation  

Importance Preclinical and clinical studies have suggested a neuroprotective effect of remote ischemic conditioning (RIC), which involves repeated occlusion/release cycles on bilateral upper limb arteries; however, robust evidence in patients with ischemic stroke is lacking. Objective To assess the efficacy of RIC for acute moderate ischemic stroke. Design, Setting, and Participants This multicenter, open-label, blinded-end point, randomized clinical trial including 1893 patients with acute moderate ischemic stroke was conducted at 55 hospitals in China from December 26, 2018, through January 19, 2021, and the date of final follow-up was April 19, 2021. Interventions Eligible patients were randomly assigned within 48 hours after symptom onset to receive treatment with RIC (using a pneumatic electronic device and consisting of 5 cycles of cuff inflation for 5 minutes and deflation for 5 minutes to the bilateral upper limbs to 200 mm Hg) for 10 to 14 days as an adjunct to guideline-based treatment (n = 922) or guideline-based treatment alone (n = 971). Main Outcomes and Measures The primary end point was excellent functional outcome at 90 days, defined as a modified Rankin Scale score of 0 to 1. All end points had blinded assessment and were analyzed on a full analysis set. Results Among 1893 eligible patients with acute moderate ischemic stroke who were randomized (mean [SD] age, 65 [10.3] years; 606 women [34.1%]), 1776 (93.8%) completed the trial. The number with excellent functional outcome at 90 days was 582 (67.4%) in the RIC group and 566 (62.0%) in the control group (risk difference, 5.4% [95% CI, 1.0%-9.9%]; odds ratio, 1.27 [95% CI, 1.05-1.54]; P = .02). The proportion of patients with any adverse events was 6.8% (59/863) in the RIC group and 5.6% (51/913) in the control group. Conclusions and Relevance Among adults with acute moderate ischemic stroke, treatment with remote ischemic conditioning compared with usual care significantly increased the likelihood of excellent neurologic function at 90 days. However, these findings require replication in another trial before concluding efficacy for this intervention. Trial Registration ClinicalTrials.gov Identifier: NCT03740971.
更新日期:2022-08-16
down
wechat
bug